1-4 of 4
Niove E. Jordanides
Close
Sort by
Journal Articles

Nilotinib concentration in Cell Lines and CML CD34+ Cells Is Not Mediated by Active Uptake or Efflux by Major Drug Transporters

Joanne Mountford, PhD, Andrea Davies, Niove E Jordanides, Athina Giannoudis, Claire M Lucas, Sophia Hatziieremia, Robert J Harris, Heather G Jorgensen, Munir Pirmohamed, Tessa L Holyoake, Richard E Clark
Journal: Blood
Blood (2008) 112 (11): 3205.
https://doi.org/10.1182/blood.V112.11.3205.3205
Published: 2008
Journal Articles

Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34 + CML cells

Brief Report
Heather G. Jørgensen, Elaine K. Allan, Niove E. Jordanides, Joanne C. Mountford, Tessa L. Holyoake
Journal: Blood
Blood (2007) 109 (9): 4016–4019.
https://doi.org/10.1182/blood-2006-11-057521
Published: 2007
Journal Articles

Functional ABCG2 is overexpressed on primary CML CD34 + cells and is inhibited by imatinib mesylate

Brief Report
Niove E. Jordanides, Heather G. Jorgensen, Tessa L. Holyoake, Joanne C. Mountford
Journal: Blood
Blood (2006) 108 (4): 1370–1373.
https://doi.org/10.1182/blood-2006-02-003145
Published: 2006
Journal Articles

Functional ABCG2 Is Expressed on CML Stem Cells and Its Inhibition Selectively Depletes CML CD34+ Cells.

Joanne C. Mountford, PhD, Diane Gilmour, BSc, Susan M. Graham, BSc, Niove E. Jordanides, BSC, MSc, Siobhan McMillan, BSc, Tessa L. Holyoake, MD, PhD.
Journal: Blood
Blood (2004) 104 (11): 716.
https://doi.org/10.1182/blood.V104.11.716.716
Published: 2004